Ocular Drug Delivery Market to be Worth US$18.124 Billion by 2025: Manufacturers Collaborating With Hospitals to Bolster Positions

Monday, July 3, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

ALBANY, New York, July 3, 2017 /PRNewswire/ --

The global Ocular Drug Delivery Technology Market is consolidated

in nature. The top three companies operating in the market, namely Santen Pharmaceutical Co., Ltd., Alimera Sciences, and Valeant Pharmaceuticals International, Inc. (Bausch & Lomb Incorporated) account for over half the share in it. Of them, Santen
Pharmaceuticals and Valeant Pharmaceuticals have a stronghold over the market because of their wide array of topical ocular drug products. Alimera Sciences captured 14% to 18% market share in 2016 due to commercialization of Iluvien manufactured by pSivida Corp.

Keen manufacturers - both large and small regional ones - in the global ocular drug delivery technology market are collaborating with hospitals and other suppliers or acquiring other companies in order to bolster their positions. They are also looking to expand their share with a robust pipeline of products in ophthalmic sector. Competition in the market will likely heat up in the near future on the back of favorable reimbursement policies of governments and increasing number of research grants.

A report by Transparency Market Research predicts the global Ocular Drug Delivery Technologies Market to expand at a steady 6.8% CAGR between 2017 and 2025 to become worth US$18.124 bn by 2025 end, vis-ā-vis revenue from US$ 10.2 bn in 2016.

Helpful Reimbursement Policies Makes North America Market Leader 

Depending upon the type of technology, the global ocular drug delivery technology market can be segmented into topical, ocular inserts, iontophoresis, intraocular implants, and in-situ gel and punctal plugs, among others. Of them, the topical segment dominates the market revenue-wise. Going forward too, the topical segment is expected to retain its leading share of about 50.2% in revenue till 2025. This is mainly because of the growing pool of elderly and the rising number of regional players in the ophthalmic technology market.

Geographically, the key segments of the global ocular drug delivery technology market are North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America, at present, is a dominant region because of the strong demand for targeted drug delivery to the posterior eye and concentration of prominent manufacturers. In 2016, the region held a substantial 52.5% share in the market.

Inquire for a sample of the report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2869

Rising Instances of Glaucoma Pushing up Demand 

Some of the primary growth drivers in the global ocular drug delivery technology market is the low bioavailability of drugs in conventional ocular therapies, increasing occurrence of glaucoma and macular degeneration, increasing preference among patients for targeted ocular drug delivery techniques, and approval of the FDA for new ocular drug delivery techniques.

However, there are a number of factors serving to restrain the market as well. As per the lead analyst of the TMR report: "Ocular inserts and implants provide advantages such as high corneal penetration, greater dissolution area, and sustained release of medication. However, the foreign body sensation in the eye due to the solidity of the implants lead to discomfort accompanied by irritation, drug dilution, and excessive lachrymation. Therefore, even though they provide enhanced drug delivery alternatives, the discomfort is likely to arrest the growth of this segment."

This review is based on the findings of a TMR report, titled, "Ocular Drug Delivery Technology Market (Technology - Topical, Ocular Inserts (Non-Erodible and Erodible), Iontophoresis, Intraocular Implants (Biodegradable and Non-Biodegradable), and In Situ Gel & Punctal Plugs; Formulation Type - Suspension, Solution, Emulsion, Liposomes & Nanoparticles, and Ointments; Disease Type - Glaucoma, Diabetic Retinopathy, Macular Degeneration, Diabetic Macular Edema, and Cataract; End User - Hospitals, Ambulatory Surgical Centers, Ophthalmic Clinics, and Homecare Settings) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025."

Browse Press Release: http://www.transparencymarketresearch.com/pressrelease/ocular-drug-delivery-technologies.htm

Global Ocular Drug Delivery Technology Market, by Technology 

  • Topical
  • Ocular Insert

       - Erodible        - Non-Erodible

  • Iontophoresis
  • Intraocular Implants

       - Biodegradable        - Non-Biodegradable

  • In Situ Gel & Punctal Plugs  
  • Others

Global Ocular Drug Delivery Technology Market, by Formulation Type 

  • Solution
  • Suspension
  • Emulsion
  • Liposomes & Nanoparticles
  • Ointment

Global Ocular Drug Delivery Technology Market, by Disease Type 

  • Glaucoma
  • Macular Degeneration
  • Diabetic Retinopathy
  • Cataract
  • Diabetic Macular Edema
  • Dry Eye Syndrome
  • Others

Global Ocular Drug Delivery Technology Market, by End user 

  • Hospitals
  • Ambulatory Surgical centers
  • Ophthalmic Clinics
  • Homecare Settings

Global Ocular Drug Delivery Technology Market, by Region 

  • North America - U.S. - Canada
  • Europe - Germany - U.K. - France - Italy - Spain - Russia  - Rest of Europe
  • Asia Pacific - India - China - Japan - Australia & New Zealand - Rest of Asia Pacific
  • Latin America - Brazil - Mexico - Rest of Latin America
  • Middle East & Africa - GCC Countries - South Africa - Rest of Middle East & Africa

Browse Related Research Report: 

Pulmonary Drug Delivery Devices Market (Product Type - Dry Powder Inhalers, Metered Dose Inhalers and Nebulizers; Application - Asthma, COPD, and Cystic Fibrosis; Distribution Channel - Retail Pharmacies, Hospital Pharmacies, and E-commerce) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024


Needle Free Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023


Nanotechnology Drug Delivery Market (By Technology - Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, and Others; By Application - Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023


About Us: 

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us: Transparency Market Research 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Blog: http://www.tmrblog.com/

SOURCE Transparency Market Research

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store